Login / Signup

Validation for models for tumor recurrence after liver transplantation in hepatectomy patients.

Sung Joon KimJong Man KimNam-Joon YiGyu Seong ChoiKwang-Woong LeeKyung-Suk SuhJae-Won Joh
Published in: Annals of surgical treatment and research (2022)
The MoRAL score can be used to predict early recurrence in patients with HCC who undergo curative HR. Using this model, other treatments could be considered for patients with early recurrence predicted after HR.
Keyphrases
  • end stage renal disease
  • free survival
  • prognostic factors
  • newly diagnosed
  • ejection fraction
  • peritoneal dialysis
  • decision making
  • liver metastases
  • clinical evaluation